Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emanuela Signori

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitisChiara Nicolò, Michela Sali, Gabriele Di Sante, et al.
Cancer Letters|May 15, 2007
Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinomaMarina Scintu, Rita Vitale, Maria Prencipe, et al.
European Journal of Epidemiology|March 24, 2007
Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infectionPaola Parrella, Davide Seripa, Maria G Matera, et al.
World Journal of Gastroenterology|January 21, 2006
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumorPaola Mazzarelli, Paola Parrella, Davide Seripa, et al.
Molecular Cancer|December 4, 2018
EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA driversMariangela De Robertis, Tommaso Mazza, Caterina Fusilli, et al.
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
EMBO Molecular Medicine|October 5, 2013
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formationRossella Lucá, Michele Averna, Francesca Zalfa, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology|November 23, 2015
Designing a broad-spectrum integrative approach for cancer prevention and treatmentKeith I Block, Charlotte Gyllenhaal, Leroy Lowe, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Journal of Immunology (Baltimore, Md. : 1950)|December 2, 2009
Mycobacterium smegmatis expressing a chimeric protein MPT64-proteolipid protein (PLP) 139-151 reorganizes the PLP-specific T cell repertoire favoring a CD8-mediated response and induces a relapsing experimental autoimmune encephalomyelitisChiara Nicolò, Michela Sali, Gabriele Di Sante, et al.
Cancer Letters|May 15, 2007
Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinomaMarina Scintu, Rita Vitale, Maria Prencipe, et al.
European Journal of Epidemiology|March 24, 2007
Lack of association between genetic variants in the mannose-binding lectin 2 (MBL2) gene and HPV infectionPaola Parrella, Davide Seripa, Maria G Matera, et al.
World Journal of Gastroenterology|January 21, 2006
DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumorPaola Mazzarelli, Paola Parrella, Davide Seripa, et al.
Molecular Cancer|December 4, 2018
EphB2 stem-related and EphA2 progression-related miRNA-based networks in progressive stages of CRC evolution: clinical significance and potential miRNA driversMariangela De Robertis, Tommaso Mazza, Caterina Fusilli, et al.
Cancer Research|June 5, 2007
Alternative BCR/ABL splice variants in Philadelphia chromosome-positive leukemias result in novel tumor-specific fusion proteins that may represent potential targets for immunotherapy approachesGisella Volpe, Alessandro Cignetti, Cristina Panuzzo, et al.
EMBO Molecular Medicine|October 5, 2013
The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formationRossella Lucá, Michele Averna, Francesca Zalfa, et al.
Seminars in Cancer Biology|March 31, 2015
Immune evasion in cancer: Mechanistic basis and therapeutic strategiesDass S Vinay, Elizabeth P Ryan, Graham Pawelec, et al.
Seminars in Cancer Biology|November 23, 2015
Designing a broad-spectrum integrative approach for cancer prevention and treatmentKeith I Block, Charlotte Gyllenhaal, Leroy Lowe, et al.
Pageof 5